Long-term oxygen therapy in COPD: what is the evidence?
- PMID: 35817071
- DOI: 10.1016/S2213-2600(22)00225-9
Long-term oxygen therapy in COPD: what is the evidence?
Conflict of interest statement
The Cologne study group, of which WW and FSM are both members, received open research grants from Weinmann (Germany), Vivisol (Germany), Löwenstein Medical (Germany), VitalAire (Germany), Phillips Respironics (USA), and GCI (Great Britain). WW has received speaking fees from Löwenstein Medical/Germany. FSM declares no competing interests.
Comment on
-
Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis.Lancet Respir Med. 2022 Nov;10(11):1029-1037. doi: 10.1016/S2213-2600(22)00179-5. Epub 2022 Jul 8. Lancet Respir Med. 2022. PMID: 35817074
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
